Tag: Multiple Myeloma
Alternative to Lenalidomide ID’d for Maintenance in Multiple Myeloma
Maintenance therapy with carfilzomib, lenalidomide, and dexamethasone may be superior for multiple myeloma after autologous stem cell transplantation
Inflammatory-Nutritional Score Helps Predict Survival in New Multiple Myeloma
Nomogram based on inflammatory-nutritional score, other factors exhibits better performance than other staging systems for multiple myeloma
Body Mass Index Tied to Multiple Myeloma Survival
Decreased survival seen for both underweight and severe obesity in newly diagnosed patients
Mass Spectrometry Can Monitor Treatment Response in Multiple Myeloma
Patients converting from mass spectrometry positivity to negativity had excellent progression-free survival, while those converting to positivity progressed early
Delay in Time to Antibiotics Permissible for Inpatient Neutropenic Fever
Time to antibiotics does not significantly affect overall survival at 180 days in patients with hematologic malignancy who develop inpatient neutropenic fever
Renal Impairment Linked to Worse Prognosis in IgD Multiple Myeloma
Median survival significantly shorter for patients with renal impairment versus those with no renal impairment
Significant Treatment Attrition Rate Seen in Multiple Myeloma
In patients receiving autologous stem cell transplant, 57.6 percent advanced to second-line treatment, 32.6 percent to third-line
Options Explored for MM That Relapses After BCMA CAR T Therapy
Salvage treatments and outcomes examined for patients with multiple myeloma that relapses after B-cell maturation antigen-directed CAR T therapy
Photon-Counting Detector CT Helps ID Multiple Myeloma Lesions
Use of PCD CT images with convolutional neural network denoising improves viewing of pathologic abnormalities, detects lytic lesions
